(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

COMPOSIÇÃO TÓPICA DE CLAREAMENTO DE PELE E MÉTODO DE CLAREAMENTO DE PELE

ArquivadaInvention PatentPCT · EP2014072000

Application data

Number

112016008841

Type

Invention Patent

Filing

10/14/2014

Publication

08/01/2017

PCT

EP2014072000

Progress at the INPI

  1. Filing10/14/14
  2. Publication08/01/17
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 10/14/2014 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 10/23/2018. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

UNILEVER N.V

NL

See this company's full portfolio

Inventors

M. G. (pessoa física)

GB

R. G. (pessoa física)

GB

R. G. (pessoa física)

GB

Technical data

IPC Classification

Priority claims

EP

13190364.3 · 10/25/2013

Abstract

ÿþABSTRACTCOMPOSIÇÃO TÓPICA DE CLAREAMENTO DE PELE E MÉTODO DE CLAREAMENTO DE PELEDesired skin colour is a major unmet consumer need around the world and especially in Asia. Consumers particularly desire even skin colour, absence of age spots (solar lentigines), absence of hyperpigmentation and lighter overall skin tone. One solution is to use biological actives that reduce the activity of melanocyte cells in skin. These cells, present in the basal layer of the epidermis, make the dark coloured pigment melanin and export it, in small export vesicles called melanosomes, to the neighbouring keratinocytes. It is well described in the literature that compounds which reduce melanin synthesis when topically applied to the skin will reduce skin darkness over time and can generate a more even skin tone. Tyrosinase is a very popular target for the regulation of melanocyte pigment production. However effective inhibitors of tyrosinase are bedevilled by safety issues causing, for example, melanocyte cell death, permanent depigmentation, irritation and allergic reactions. Often effective inhibitors kill melanocytes (for example hydroquinone) or cause sensitisation reactions. There is therefore a great need for safe and effective inhibitors of skin pigment production that work through an alternative safe mechanism. The inventors have observed that selected compounds of the same generic structure: or a salt thereof;wherein R1, R2, R3, R4 and R5 may be independently selected from the group consisting of -H, -halide, and methyl, ethyl, propyl, iso-propyl, butyl, and t-butyl moieties, inhibit melanin production in MelanodermsTM.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

10/23/2018

RPI 2494

Arquivamento - Art. 33 da LPI

#11.1

06/19/2018

RPI 2476

Notificação de entrada na fase nacional - PCT

#1.3

Publicação automática da admissibilidade da fase nacional depositado via PCT . Tratado de cooperação em matéria de Patentes, conforme Instrução Normativa nº 02, de 06/06/2017 publicada na RPI nº 2422, de 06/06/2017.

08/01/2017

RPI 2430

Alteração de dados cadastrais

#1.1

05/03/2016

RPI 2365

Related

From the same holder

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.